Keyword: Human Genome replacement of board
News
29.06.2012
- GlaxoSmithKline has once again extended its $2.6 billion offer to buy long-time partner Human Genome Sciences until July 20 as a hostile stand-off with the U.S. biotech company...
News
15.06.2012
- U.S. biotech company Human Genome Sciences said on Friday it had set a bid date of July 16 for definitive offers to acquire the company and again urged hostile bidder...
News
30.05.2012
- GlaxoSmithKline plans to launch a campaign to replace the entire board of Human Genome Sciences with its own nominees, stepping up its $2.6 billion hostile bid for the U.S. biotech...
